INIS
nervous system diseases
100%
promoters
66%
control
58%
mitochondria
41%
genotype
25%
genes
25%
variations
25%
nucleotides
25%
plasmids
16%
transcription factors
16%
risks
16%
patients
16%
fission
16%
comparative evaluations
8%
proteins
8%
membranes
8%
distribution
8%
translocation
8%
losses
8%
messenger-rna
8%
construction
8%
asia
8%
pcr
8%
neurons
8%
pathogenesis
8%
humans
8%
cloning
8%
motors
8%
levels
8%
data
8%
modifications
8%
blood
8%
populations
8%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Single-Nucleotide Polymorphism
42%
Genotyping
42%
Allele
28%
Mitochondrial Fission
28%
Transcription Factors
28%
FOXA1
28%
Plasmid
28%
CCAAT Enhancer Binding Protein Beta
28%
Transfection
14%
Motor Control
14%
Dopaminergic
14%
Biogenesis
14%
Mitochondrion
14%
Prevalence
14%
TFAP2A
14%
Messenger RNA
14%
Peripheral Blood Mononuclear Cell
14%
Outer Mitochondrial Membrane
14%
Mitochondrial Disorder
14%
Dynamin
14%
Gene Promoter
14%
Transactivation
14%
Posttranslational Modification
14%
Neuroscience
Parkinson's Disease
100%
Promoter Region
72%
Single-Nucleotide Polymorphism
27%
Transcription Factors
18%
CCAAT Enhancer Binding Protein Beta
18%
Mitochondrial Fission
18%
Plasmid
18%
FOXA1
18%
Motor Control
9%
Complementary DNA
9%
Transfection
9%
Peripheral Blood Mononuclear Cell
9%
Messenger RNA
9%
Mitochondrion
9%
Substantia nigra
9%
Outer Membrane
9%
Transactivation
9%
Posttranslational Modification
9%
Alzheimer's Disease
9%
TFAP2A
9%
Dynamin I
9%
Age-Related Neurodegenerative Disorder
9%
Dopaminergic Neuron
9%